Form 4: Aptevo Therapeutics Director Reports Stock Transaction
Insider Transaction (Form 4)
Grady Grant Iii, a Director of Aptevo Therapeutics Inc., reported multiple transactions in common stock on August 6, 2026.
Summary
- Option exercise/conversion: acquired 400 Common Stock on August 6, 2026; holds 1,150 after (Direct).
- Option exercise/conversion: disposed of 400 Restricted Stock Unit on August 6, 2026 (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Grady Grant Iii — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-06 | Option exercise/conversion | Common Stock | 400 | — | — | 1,150 |
| 2026-08-06 | Option exercise/conversion | Restricted Stock Unit | 400 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-06 | Option exercise/conversion (400 shares) |
| 2026-08-06 | Option exercise/conversion (400 shares) |
Keywords
insider transaction, Form 4, APVO, Aptevo Therapeutics Inc., neutral, Grady Grant Iii
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.